Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 898 | 898 | 829 | 480 | 629 | 666 |
Fund Return | -10.24% | -10.24% | -17.12% | -21.71% | -8.86% | -3.98% |
Place in category | 31 | 31 | 22 | 12 | 8 | 6 |
% in Category | 87 | 87 | 67 | 79 | 100 | 100 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
001668 | 20.35B | 11.70 | 5.01 | - | ||
China Universal Consumer Industries | 13.91B | 2.53 | -12.90 | 16.72 | ||
China Universal Selective Mixed Sec | 9.46B | 7.23 | -13.95 | 12.08 | ||
China Universal Blue Chip Equity Fu | 4.62B | 0.20 | -14.32 | 12.30 | ||
China Universal CSI 300 Dynamic Str | 4.21B | 5.34 | -1.71 | 9.92 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
E Fund Mid Small Cap | 14.39B | -0.42 | -15.32 | 15.36 | ||
Fullgoal China Small Cap Stock Fund | 2.74B | 3.06 | -9.71 | 5.66 | ||
FTS Great China Selec Bal Fd QDII | 1.72B | 2.66 | -12.70 | - | ||
Harvest Overseas China QDII | 1.53B | 1.48 | -17.86 | -0.50 | ||
IGW Greater China Equity Fund[QDII] | 994.82M | -5.24 | -12.53 | 4.98 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Sichuan Kelun Biotech | CNE1000062J1 | 11.96 | 164.00 | -2.26% | |
Hansoh Pharmaceutical Group | KYG549581067 | 10.15 | 18.24 | +0.33% | |
Keymed Biosciences Inc | - | 8.51 | - | - | |
Genscript Biotech Corp | KYG3825B1059 | 7.38 | 12.00 | -2.76% | |
Remegen | CNE1000048G6 | 6.07 | 29.80 | -0.67% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Neutral | Sell |
Technical Indicators | Strong Buy | Strong Buy | Strong Sell |
Summary | Strong Buy | Buy | Strong Sell |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review